why Geron Corp. [GERN] is a Good Choice for Investors After New Price Target of $6.07

Geron Corp. [NASDAQ: GERN] loss -5.09% or -0.2 points to close at $3.73 with a heavy trading volume of 6690961 shares.

The daily chart for GERN points out that the company has recorded 93.26% gains over the past six months.

If we look at the average trading volume of 13.29M shares, GERN reached to a volume of 6690961 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Geron Corp. [GERN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GERN shares is $6.07 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GERN stock is a recommendation set at 1.29. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Robert W. Baird have made an estimate for Geron Corp. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on April 30, 2024. While these analysts kept the previous recommendation, TD Cowen raised their target price to Buy. The new note on the price target was released on April 29, 2024, representing the official price target for Geron Corp. stock. Previously, the target price had yet another raise from $4 to $5, while Needham kept a Buy rating on GERN stock.

The Average True Range (ATR) for Geron Corp. is set at 0.28, with the Price to Sales ratio for GERN stock in the period of the last 12 months amounting to 4254.57. The Price to Book ratio for the last quarter was 6.39, with the Price to Cash per share for the same quarter was set at 0.75.

Trading performance analysis for GERN stock

Geron Corp. [GERN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.90. With this latest performance, GERN shares gained by 12.35% in over the last four-week period, additionally plugging by 93.26% over the last 6 months – not to mention a rise of 39.70% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GERN stock in for the last two-week period is set at 54.46, with the RSI for the last a single of trading hit 49.82, and the three-weeks RSI is set at 56.87 for Geron Corp. [GERN]. The present Moving Average for the last 50 days of trading for this stock 3.11, while it was recorded at 3.92 for the last single week of trading, and 2.42 for the last 200 days.

Geron Corp. [GERN]: A deeper dive into fundamental analysis

Geron Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.67 and a Current Ratio set at 3.67.

Geron Corp. [GERN]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GERN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Geron Corp. go to 5.00%.

An analysis of Institutional ownership at Geron Corp. [GERN]

The top three institutional holders of GERN stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in GERN stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in GERN stock with ownership which is approximately 5.8386%.